Maximum Recommended Dosage of Midazolam for Adults and Pediatric Patients
The maximum recommended dose of midazolam varies by indication, route of administration, and patient population, with intravenous doses generally not exceeding 6 mg for adults in procedural sedation and 5 μg/kg/min for pediatric patients in refractory status epilepticus. 1, 2
Adult Dosing
Intravenous Administration
- Procedural Sedation:
Intramuscular Administration
- Preoperative Sedation:
- Standard dose: 0.07-0.08 mg/kg IM (approximately 5 mg)
- Maximum: No specific maximum stated, but dose should be reduced in elderly, COPD patients, and those on other CNS depressants 2
Continuous Infusion
- Maintenance of Sedation:
- Loading dose: 0.01-0.05 mg/kg
- Infusion rate: 0.02-0.10 mg/kg/hr (1-7 mg/hr)
- Higher rates may occasionally be required 2
Pediatric Dosing
Intravenous Administration
- Procedural Sedation:
Intramuscular Administration
- Procedural Sedation:
- Standard dose: 0.1-0.15 mg/kg
- For anxious patients: Up to 0.5 mg/kg
- Maximum: Total dose usually does not exceed 10 mg 2
Seizure Management
Intramuscular for Acute Seizures:
Intravenous for Refractory Status Epilepticus:
Special Considerations
Respiratory Monitoring:
Dose Adjustments Required:
Administration Rate:
- Administer IV doses slowly (over at least 2 minutes)
- Allow 2-3 minutes between doses to evaluate effect 2
Reversal Agent:
Clinical Pitfalls to Avoid
- Rapid administration can cause severe respiratory depression and hypotension
- Failure to reduce dose when combining with opioids or other CNS depressants
- Inadequate monitoring of respiratory status, especially in the first 30 minutes after administration
- Overlooking age-related sensitivity in elderly patients and very young children
- Using standard adult dosing for pediatric patients (must calculate on mg/kg basis)
The dosing recommendations above represent maximum doses under optimal monitoring conditions. In clinical practice, using the lowest effective dose and careful titration is essential for patient safety.